* Note: Prices are in Million (M) USD.
Description:
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications. The company is headquartered in Stoughton, Massachusetts.
These criteria used Company's Cash, EBITDA and Debt balance to determines its fair value:
Cash : $71 M
Debt : $859 M
EBITDA : $365 M
Net Debt (Debt - Cash): $789 M
Since Net Debt is covered by EBITDA within 3 years, 1 points assigned.
This criteria used industry in which company operates:
Sector: Health Care
Industry: Drug Manufacturers - Specialty & Generic
Based on industry, 3 points assigned.
This criteria used Company's Price To Earning (P/E) Ratio to determines its fair value:
Forward PE Ratio: 10.46
Since Forward PE Ratio is less than 15, 5 points assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Average Free Cash Flow: $74 M
Average Revenue: $238 M
Revenue Converted To Free Cash FLow(%): 31%
Since Free Cash Flow (FCF) to Revenue percentage is greater than 25, 5 points assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2024-12-31): $631 M
Revenue 4 Years Ago (2020-12-31): $310 M
Last 5 Years Average Revenue Growth: 21%
Since Revenue Growth is greater than 20, 5 points assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2024-12-31): $40 M
Share Count 5 Years Ago (2020-12-31): $35 M
Company is not buying back its own shares, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Next Year Earnings Per Share (EPS): $5.12
Trailing 12-Month Earnings Per Share (EPS): $1.18
Average Earnings Per Share (EPS): $3.15
Dividend Per Share (DPS): $0
Payout Ratio: 0%
Dividend Yield: 0%
Since Dividend Per Share is less than or equal to 0, 0 point assigned.
Since Dividend Yield is less than 1, 0 point assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Average ROE: -39%
Since Average ROE is negative, 0 point assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $33
52-Week Low: $23
Threshold Price (15% Above 52-Week Low): $27
Since Current price is not within 15% threshold, 0 point assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $987 M
Since Market Cap is less than 10B, 1 point assigned.
% Exposure to Total Portfolio
Based on the market cap, we recommend do not exceed 1% exposure of Total Portfolio.
Value-Trade has assigned 20 points to above Collegium Pharmaceutical Inc (COLL) stock.
Last 6 Years Avg PE (Limited to last 6 years of EPS data) 12, Fair Value PE 15, Industry Based PE is 15 and Growth based PE is 15. Based on these all values average assigned is 14.25.
Value-Trades has assined P/E value 14.25. Since an average (Current Year EPS + Next Year EPS) earning per share is $3.15.
The fair value of Collegium Pharmaceutical Inc (COLL) stock should be (14.25 x $3.15) = $44.89
